Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.


Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

Adding radiation therapy to prostate cancer surgery has been a tough call. New science eases the dilemma.

One of the thorniest dilemmas posed by prostate cancer is whether, and when, to give radiation therapy — with its potential bad side effects — to men after surgery to remove the prostate gland.

Now, three new randomized clinical trials — the gold-standard type of study — and a statistical “meta-analysis” of their results conclude that routinely giving post-surgical radiation does not improve outcomes after five years, compared with giving radiation only if the PSA (prostate-specific antigen) blood test signals a cancer recurrence. The papers were published last month in the Lancet and Lancet Oncology.

Read more about the new trials here.

source: Marie McCullough - The Philadelphia Inquirer